{"id":"https://openalex.org/W7172261069","doi":"https://doi.org/10.6084/m9.figshare.33143864","title":"Real-world evidence on off-label underdosing of direct oral anticoagulants in Asian patients with atrial fibrillation: prescribing patterns, determinants, and outcomes","display_name":"Real-world evidence on off-label underdosing of direct oral anticoagulants in Asian patients with atrial fibrillation: prescribing patterns, determinants, and outcomes","publication_year":2026,"publication_date":"2026-08-03","ids":{"openalex":"https://openalex.org/W7172261069","doi":"https://doi.org/10.6084/m9.figshare.33143864"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.33143864","doi":"https://doi.org/10.6084/m9.figshare.33143864","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33143864","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.33143864","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048848026","display_name":"Pajaree Mongkhon","orcid":"https://orcid.org/0000-0002-3050-1557","observed_orcids":["https://orcid.org/0000-0002-3050-1557"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pajaree Mongkhon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144283347","display_name":"Tanaphorn Koonlachad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanaphorn Koonlachad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144251328","display_name":"Purachai Bvornphattanasakul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Purachai Bvornphattanasakul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106680609","display_name":"Sirayut Phatthanasobhon","orcid":"https://orcid.org/0000-0001-9923-7013","observed_orcids":["https://orcid.org/0000-0001-9923-7013"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sirayut Phatthanasobhon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117460289","display_name":"Supisara Pholprasittito","orcid":"https://orcid.org/0009-0002-3993-8154","observed_orcids":["https://orcid.org/0009-0002-3993-8154"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Supisara Pholprasittito","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039276301","display_name":"Supharat Wattanasombat","orcid":"https://orcid.org/0000-0002-2406-7504","observed_orcids":["https://orcid.org/0000-0002-2406-7504"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Supharat Wattanasombat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5144258848","display_name":"Natrawee Bureekam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natrawee Bureekam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atrial-fibrillation","display_name":"atrial fibrillation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.8640000224113464},{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":0.9459999799728394},{"id":"https://openalex.org/keywords/apixaban","display_name":"apixaban","score":0.9959999918937683},{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":1.0},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.8130000233650208},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.6230000257492065},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.7860000133514404},{"id":"https://openalex.org/keywords/old-age","display_name":"old age","score":0.777999997138977},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.7490000128746033},{"id":"https://openalex.org/keywords/thailand","display_name":"Thailand","score":0.878000020980835},{"id":"https://openalex.org/keywords/anticoagulation-management","display_name":"anticoagulation management","score":0.5299999713897705},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8999000191688538},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.7720999717712402},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.5659999847412109},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.522599995136261},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.49950000643730164},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4932999908924103},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.48969998955726624},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.48260000348091125},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.47279998660087585},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.44179999828338623},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4339999854564667},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.43299999833106995},{"id":"https://openalex.org/C3017811039","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Major bleeding","level":3,"score":0.42980000376701355},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4065999984741211},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.3935999870300293},{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.3698999881744385},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35429999232292175},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.350600004196167},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.34860000014305115},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.34060001373291016},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.3285999894142151},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.32499998807907104},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.3221000134944916},{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.30559998750686646},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3027999997138977},{"id":"https://openalex.org/C2777683767","wikidata":"https://www.wikidata.org/wiki/Q708653","display_name":"Death certificate","level":4,"score":0.299699991941452},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2953999936580658},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.274399995803833},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.2743000090122223},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.25609999895095825},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.25450000166893005}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.33143864","doi":"https://doi.org/10.6084/m9.figshare.33143864","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33143864","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.33143864.v1","doi":"https://doi.org/10.6084/m9.figshare.33143864.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33143864.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.33143864","doi":"https://doi.org/10.6084/m9.figshare.33143864","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33143864","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402077588","https://openalex.org/W4302009389","https://openalex.org/W3163999946","https://openalex.org/W4200124678","https://openalex.org/W2914431396","https://openalex.org/W4379093351","https://openalex.org/W3164766860","https://openalex.org/W4327862342","https://openalex.org/W4388420861","https://openalex.org/W2981542323"],"abstract_inverted_index":{"Off-label":[0,170,542],"underdosing":[1,143,171,468,543],"of":[2,37,91,175,209,319,346,371],"direct":[3,210],"oral":[4,211],"anticoagulants":[5,212],"(DOACs)":[6,213],"is":[7,232,358],"common":[8],"among":[9],"Asian":[10,23,193,223,466,540],"patients":[11,66,176],"with":[12,147,181,217,279,332,441,514],"atrial":[13,218],"fibrillation":[14,219],"(AF),":[15,220],"partly":[16],"reflecting":[17],"concerns":[18,227],"about":[19,228],"bleeding,":[20],"yet":[21],"Southeast":[22,399],"data":[24,402],"remain":[25],"limited.":[26,405],"This":[27,199,375,392],"study":[28,200,393],"aimed":[29],"to":[30,102,140,226,273,315,423,484,496,559,572],"characterize":[31],"DOAC":[32,283,428,503,579],"dosing":[33,504,580],"patterns,":[34],"identify":[35],"predictors":[36],"off-label":[38,439,458,512,532],"underdosing,":[39,440,513],"and":[40,44,110,121,133,194,248,287,310,410,416,426,435,500,508,576],"evaluate":[41,103],"associated":[42,146,180],"effectiveness":[43],"safety":[45],"outcomes.":[46,112,374],"We":[47],"conducted":[48,202],"a":[49,316,321,453,461,527,535],"retrospective":[50],"cohort":[51],"using":[52,250],"electronic":[53,264],"health":[54,265],"records":[55,266],"(EHRs)":[56,267],"from":[57,268,398],"two":[58,269],"tertiary":[59],"hospitals":[60,270],"in":[61,173,184,191,222,238,241,271,343,369,465,474,539,549],"Thailand":[62,272],"(2015\u20132023).":[63],"Incident":[64],"AF":[65,280],"initiating":[67],"dabigatran,":[68],"rivaroxaban,":[69],"apixaban,":[70],"or":[71,81,106,160,186,259,348,367,481,556],"edoxaban":[72],"were":[73,76,117,313,339,456,530],"included.":[74],"Doses":[75],"classified":[77],"as":[78,257],"on-label,":[79],"underdosed,":[80,118],"overdosed":[82],"based":[83,388],"on":[84,389],"guideline":[85],"criteria.":[86],"Propensity":[87],"score-based":[88],"inverse":[89],"probability":[90],"treatment":[92,284],"weighting":[93],"(PS-IPTW)":[94],"Cox":[95],"proportional":[96],"hazards":[97],"regression":[98],"models":[99],"was":[100,127,144,178,201],"used":[101,263],"ischemic":[104,477,552],"stroke":[105,258,347],"systemic":[107,479,554],"embolism":[108],"(ISSE)":[109],"bleeding":[111,161,482,557],"Among":[113],"553":[114,275],"patients,":[115],"20.4%":[116,455,529],"6.3%":[119],"overdosed,":[120],"73.2%":[122],"received":[123,296,302,329,335,450,524],"on-label":[124,141,451,485,525,560],"dosing.":[125],"Rivaroxaban":[126],"most":[128,292,305,445,518],"frequently":[129,446,519],"underdosed.":[130],"Older":[131,308,433,506],"age":[132,309,434,507],"diabetes":[134,312,436,509],"mellitus":[135],"independently":[136,437,510],"predicted":[137,438,511],"underdosing.":[138],"Compared":[139],"dosing,":[142],"not":[145,179,363],"ISSE":[148,185],"(adjusted":[149],"hazard":[150],"ratio":[151],"[aHR]":[152],"0.48,":[153],"95%":[154,164],"CI":[155,165],"0.11\u20132.16;":[156],"p":[157,167],"=":[158,168],"0.336)":[159],"(aHR":[162],"1.06,":[163],"0.30\u20133.73;":[166],"0.924).":[169],"occurred":[172],"one-fifth":[174],"but":[177,299],"significant":[182,454,472,528,547],"differences":[183,342],"bleeding.":[187,229,260,349],"Larger,":[188],"prospective":[189],"studies":[190,422,495,571],"broader":[192],"non-Asian":[195],"populations":[196],"are":[197,403],"warranted.":[198],"because":[203],"doctors":[204],"sometimes":[205],"prescribe":[206],"lower-than-recommended":[207,303],"doses":[208,252,331,357],"for":[214,379,420,476,491,551,567],"people":[215,276,293,327],"living":[216],"especially":[221],"populations,":[224],"due":[225],"However,":[230],"it":[231,361],"unclear":[233],"how":[234],"often":[235],"this":[236],"happens":[237],"real-world":[239,396,494,570],"practice":[240],"Thailand,":[242],"what":[243],"factors":[244],"influence":[245],"these":[246],"decisions,":[247],"whether":[249],"lower":[251,322,330,356],"affects":[253],"patient":[254],"outcomes":[255,499,575],"such":[256],"The":[261],"researchers":[262],"follow":[274],"newly":[277],"diagnosed":[278],"who":[281,328,334],"started":[282],"between":[285],"2015":[286],"2023.":[288],"They":[289],"found":[290],"that":[291,353],"(about":[294],"73%)":[295],"recommended":[297,336],"doses,":[298,304,337],"around":[300],"20%":[301],"commonly":[306],"rivaroxaban.":[307],"having":[311],"linked":[314],"higher":[317],"likelihood":[318],"receiving":[320],"dose.":[323],"Importantly,":[324],"when":[325],"comparing":[326],"those":[333],"there":[338],"no":[340,470,545],"meaningful":[341],"the":[344,377,418,444,489,517,565],"risks":[345,475,550],"These":[350,562],"results":[351],"suggest":[352],"although":[354],"prescribing":[355,414],"relatively":[359],"common,":[360],"may":[362],"provide":[364],"clear":[365],"benefits":[366],"harms":[368],"terms":[370],"major":[372],"clinical":[373,463,498,537,574],"highlights":[376],"need":[378,419,490,566],"careful,":[380],"individualized":[381,502,578],"decision-making":[382],"rather":[383],"than":[384],"routine":[385],"dose":[386],"reduction":[387],"concern":[390],"alone.":[391],"adds":[394],"important":[395],"evidence":[397],"Asia,":[400],"where":[401],"still":[404],"It":[406],"helps":[407],"clinicians,":[408],"researchers,":[409],"policymakers":[411],"better":[412],"understand":[413],"patterns":[415],"supports":[417],"larger":[421],"guide":[424],"safe":[425],"effective":[427],"use":[429],"across":[430],"diverse":[431],"populations.":[432],"rivaroxaban":[442,515],"being":[443,516],"underdosed":[447,520],"agent.While":[448],"73%":[449,523],"DOACs,":[452,526],"prescribed":[457,531],"underdoses,":[459,533],"highlighting":[460,534],"persistent":[462,536],"trend":[464,538],"patients.Off-label":[467],"showed":[469,544],"statistically":[471,546],"difference":[473,548],"stroke,":[478,553],"embolism,":[480,555],"compared":[483,558],"regimens.These":[486],"findings":[487,563],"highlight":[488,564],"larger,":[492,568],"multicenter":[493,569],"confirm":[497,573],"inform":[501,577],"strategies.":[505,581],"agent.":[521],"While":[522],"patients.":[541],"regimens.":[561]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-08-04T00:00:00"}